Now that weed is either legal, kind of legal, or almost legal in several countries around the world, one of the benefits is that researchers have been able to start figure what cannabis actually does to people on a medical or biological level.
One of the most promising developments in recent medical cannabis research is into a fairly little known compound called cannflavin. It’s a variety of flavonoid, a chemical found in nearly every plant in the world. Flavonoids are semi-famous as a component of “super foods” because of their antioxidant properties.
But the specific flavonoids found in cannabis, cannflavin A and cannfalvin B, also have their own pretty special properties. According to a recent study conducted on animal cells, “Cannflavins exhibit anti-inflammatory activity that is thirty times that of aspirin.” Research also indicates that cannfalvins don’t have the potentially harmful side effects of over the counter pain relievers like aspirin and ibuprofen, which can lead to kidney damage if taken in high doses and used with alcohol.
This is not exactly brand new information in the medical community. Researchers in the 1980’s actually came to the same conclusion. The only problem is that those cannflavins are hard to get at. They make up approximately only .014% of the fresh weight of the cannabis plant, making it very difficult to synthesize in the quantities which would be useful to humans.
The significance of the new study, conducted by researchers at the University of Guleph in Canada, is that they may have actually found a workable way to produce cannflavin
The difference here is that researchers may have found a way to actually make enough cannfalvin to treat your headache. It’s all due to a process called “in silico” genome mining (just Google it) and they already took out a patent, so you can’t go doing your own rip off in silico mining, unfortunately.